North Star Investment Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36K | Hold |
13
| – | – | ﹤0.01% | 1119 |
|
|
2025
Q1 | $1.52K | Hold |
13
| – | – | ﹤0.01% | 1105 |
|
|
2024
Q4 | $1.1K | Hold |
13
| – | – | ﹤0.01% | 1149 |
|
|
2024
Q3 | $1.17K | Hold |
13
| – | – | ﹤0.01% | 1117 |
|
|
2024
Q2 | $1.05K | Hold |
13
| – | – | ﹤0.01% | 1092 |
|
|
2024
Q1 | $1.04K | Hold |
13
| – | – | ﹤0.01% | 1154 |
|
|
2023
Q4 | $1.04K | Hold |
13
| – | – | ﹤0.01% | 1107 |
|
|
2023
Q3 | $909 | Hold |
13
| – | – | ﹤0.01% | 1146 |
|
|
2023
Q2 | $934 | Hold |
13
| – | – | ﹤0.01% | 1160 |
|
|
2023
Q1 | $802 | Hold |
13
| – | – | ﹤0.01% | 1190 |
|
|
2022
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1162 |
|
|
2022
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1056 |
|
|
2022
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 1133 |
|
|
2022
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 1078 |
|
|
2021
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 1177 |
|
|
2021
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 1124 |
|
|
2021
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1040 |
|
|
2021
Q1 | $1K | Sell |
13
-100
| -88% | -$7.69K | ﹤0.01% | 1002 |
|
|
2020
Q4 | $9K | Buy |
113
+13
| +13% | +$1.04K | ﹤0.01% | 786 |
|
|
2020
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 792 |
|
|
2020
Q2 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 750 |
|